Literature DB >> 22283139

Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology.

M B Axelsen1, M Stoltenberg, R P Poggenborg, O Kubassova, M Boesen, H Bliddal, K Hørslev-Petersen, L G Hanson, M Østergaard.   

Abstract

OBJECTIVE: To determine whether dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluated using semi-automatic image processing software can accurately assess synovial inflammation in rheumatoid arthritis (RA) knee joints.
METHODS: In 17 RA patients undergoing knee surgery, the average grade of histological synovial inflammation was determined from four biopsies obtained during surgery. A preoperative series of T(1)-weighted dynamic fast low-angle shot (FLASH) MR images was obtained. Parameters characterizing contrast uptake dynamics, including the initial rate of enhancement (IRE), were generated by the software in three different areas: (I) the entire slice (Whole slice); (II) a manually outlined region of interest (ROI) drawn quickly around the joint, omitting large artefacts such as blood vessels (Quick ROI); and (III) a manually outlined ROI following the synovial capsule of the knee joint (Precise ROI). Intra- and inter-reader agreement was assessed using the intra-class correlation coefficient (ICC).
RESULTS: The IRE from the Quick ROI and the Precise ROI revealed high correlations to the grade of histological inflammation (Spearman's correlation coefficient (rho) = 0.70, p = 0.001 and rho = 0.74, p = 0.001, respectively). Intra- and inter-reader ICCs were very high (0.93-1.00). No Whole slice parameters were correlated to histology.
CONCLUSION: DCE-MRI provides fast and accurate assessment of synovial inflammation in RA patients. Manual outlining of the joint to omit large artefacts is necessary.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283139     DOI: 10.3109/03009742.2011.608375

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  19 in total

Review 1.  Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography.

Authors:  Mikkel Østergaard; Mikael Boesen
Journal:  Radiol Med       Date:  2019-03-18       Impact factor: 3.469

2.  Influence of field strength, coil type and image resolution on assessment of synovitis by unenhanced MRI--a comparison with contrast-enhanced MRI.

Authors:  Iris Eshed; Simon Krabbe; Mikkel Østergaard; Pernille Bøyesen; Jakob M Møller; Flemming Therkildsen; Ole Rintek Madsen; Mette Axelsen; Susanne Juhl Pedersen
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

3.  Pixel-by-pixel analysis of DCE-MRI curve shape patterns in knees of active and inactive juvenile idiopathic arthritis patients.

Authors:  Robert Hemke; Cristina Lavini; Charlotte M Nusman; J Merlijn van den Berg; Koert M Dolman; Dieneke Schonenberg-Meinema; Marion A J van Rossum; Taco W Kuijpers; Mario Maas
Journal:  Eur Radiol       Date:  2014-04-26       Impact factor: 5.315

4.  The diagnostic accuracy of unenhanced MRI in the assessment of joint abnormalities in juvenile idiopathic arthritis.

Authors:  Robert Hemke; Taco W Kuijpers; J Merlijn van den Berg; Mira van Veenendaal; Koert M Dolman; Marion A J van Rossum; Mario Maas
Journal:  Eur Radiol       Date:  2013-02-01       Impact factor: 5.315

5.  Perfusion in bone marrow lesions assessed on DCE-MRI and its association with pain in knee osteoarthritis: a cross-sectional study.

Authors:  Cecilie L Daugaard; Robert Gc Riis; Elisabeth Bandak; Henrik Gudbergsen; Marius Henriksen; Henning Bliddal; Mikael Boesen
Journal:  Skeletal Radiol       Date:  2019-12-09       Impact factor: 2.199

6.  Quantitative volume and dynamic contrast-enhanced MRI derived perfusion of the infrapatellar fat pad in patellofemoral pain.

Authors:  Rianne A van der Heijden; Bas A de Vries; Dirk H J Poot; Marienke van Middelkoop; Sita M A Bierma-Zeinstra; Gabriel P Krestin; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2021-01

7.  MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16.

Authors:  M Østergaard; L T H Jacobsson; C Schaufelberger; M Sejer Hansen; J W J Bijlsma; A Dudek; M Rell-Bakalarska; F Staelens; R Haake; B Sundman-Engberg; H Bliddal
Journal:  Ann Rheum Dis       Date:  2014-12-15       Impact factor: 19.103

8.  Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study.

Authors:  Signe Rifbjerg-Madsen; Anton Wulf Christensen; Mikael Boesen; Robin Christensen; Bente Danneskiold-Samsøe; Henning Bliddal; Else Marie Bartels; Henning Locht; Kirstine Amris
Journal:  BMJ Open       Date:  2014-11-13       Impact factor: 2.692

9.  Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study.

Authors:  Martin Andersen; Mikael Boesen; Karen Ellegaard; Robin Christensen; Kalle Söderström; Niels Søe; Pieter Spee; Ulrik Gw Mørch; Søren Torp-Pedersen; Else Marie Bartels; Bente Danneskiold-Samsøe; Nina Vendel; Lars Karlsson; Henning Bliddal
Journal:  Arthritis Res Ther       Date:  2014-05-05       Impact factor: 5.156

10.  Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques.

Authors:  Philip G Conaghan; Mikkel Østergaard; Michael A Bowes; Chunying Wu; Thomas Fuerst; Désirée van der Heijde; Fedra Irazoque-Palazuelos; Oscar Soto-Raices; Pawel Hrycaj; Zhiyong Xie; Richard Zhang; Bradley T Wyman; John D Bradley; Koshika Soma; Bethanie Wilkinson
Journal:  Ann Rheum Dis       Date:  2016-01-25       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.